2022 is shaping up to be another big year for the pharma industry with new trends emerging in everything from digitization to sustainability. Contract Pharma recently spoke to Ben Wylie (Senior Product Manager, ChargePoint Technology) and a number of industry leaders to find out what they think the next 12 months will look like. Ben discussed the heightened demand for cancer treatment innovation, the advancements in sterile processing and how pharmas will need to adapt to Annex 1 amendments.
Find out more on Ben’s view and the full round table discussion here
